|
JAMA Network Open |
Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge - A Cohort Study and Randomized Comparative Effectiveness Trial |
1 |
Yes |
8/1/2025 |
|
JAMA Network Open |
Effectiveness of mRNA-1273, BNT162b2, and JNJ-78436735 COVID-19 Vaccines Among US Military Personnel Before and During the Predominance of the Delta Variant |
1 |
Yes |
4/22/2025 |
|
American Medical Association |
Embracing Public Safety and Health for Improved Firearm Violence Prevention |
0.75 |
Yes |
4/2/2027 |
|
JAMA Network Open |
Emotional Exhaustion Among US Health Care Workers Before and During the COVID-19 Pandemic, 2019-2021 |
1 |
Yes |
9/23/2025 |
|
JAMA Cardiology |
Emphasizing Sexual Orientation and Gender Identity Data Capture for Improved Cardiovascular Care of the LGBTQ+ Population |
1 |
Yes |
1/24/2027 |
|
JAMA Surgery |
Entrustable Professional Activities in Surgery - A Review |
1 |
Yes |
3/13/2027 |
|
JAMA |
Eosinophilic Gastrointestinal Disease |
1 |
Yes |
3/25/2027 |
|
JAMA Ophthalmology |
Epicapsular Stars in an Asymptomatic Patient |
1 |
Yes |
6/20/2027 |
|
JAMA Dermatology |
Erythematous Plaque Studded With Papules and Pustules in an Immunocompetent Patient |
1 |
Yes |
3/6/2027 |
|
JAMA Dermatology |
Erythroderma in a Patient With Thymoma-Associated Myasthenia Gravis |
1 |
Yes |
1/3/2027 |
|
JAMA Psychiatry |
Essentials of Informed Consent to Psychedelic Medicine |
1 |
Yes |
4/10/2027 |
|
JAMA Network Open |
Estimated Clinical Trial Capacity of Sites Participating in the COVID-19 Convalescent Plasma Expanded Access Program |
1 |
Yes |
10/26/2025 |
|
JAMA Network Open |
Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes |
1 |
Yes |
9/23/2025 |
|
JAMA Network Open |
Estimated Health Outcomes and Costs of COVID-19 Prophylaxis With Monoclonal Antibodies Among Unvaccinated Household Contacts in the US |
1 |
Yes |
4/22/2025 |
|
JAMA Network Open |
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA Vaccinated and Nonvaccinated Individuals in Quebec, Canada |
1 |
Yes |
10/26/2025 |
|
JAMA Network Open |
Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England |
1 |
Yes |
11/7/2025 |
|
JAMA Network Open |
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States |
1 |
Yes |
10/26/2025 |
|
AMA Journal of Ethics |
Ethics Talk: Does Normalization of Turfing Explain Why There's No Recent Literature on It? |
0.25 |
Yes |
12/1/2026 |
|
AMA Journal of Ethics |
Ethics Talk: Environmental Services Techs Are Key to Fighting Antimicrobial Resistance |
0.25 |
Yes |
5/1/2027 |
|
AMA Journal of Ethics |
Ethics Talk: How Assumptions About Social Determinants of Health Can Mask Sources of Inequity |
0.5 |
Yes |
12/19/2026 |
